Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/36705
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRASKING, Leen-
dc.contributor.authorVANBRABANT, Kenneth-
dc.contributor.authorBOVE, Hannelore-
dc.contributor.authorPLUSQUIN, Michelle-
dc.contributor.authorDe Vusser, Katrien-
dc.contributor.authorROELS, Harry-
dc.contributor.authorNAWROT, Tim-
dc.date.accessioned2022-02-22T12:45:47Z-
dc.date.available2022-02-22T12:45:47Z-
dc.date.issued2022-
dc.date.submitted2022-02-08T14:14:13Z-
dc.identifier.citationEnvironmental Health, 21 (1) (Art N° 24)-
dc.identifier.urihttp://hdl.handle.net/1942/36705-
dc.description.abstractBackground: Ambient fine particulate matter (PM < 2.5 μm, PM 2.5) is gaining increasing attention as an environmental risk factor for health. The kidneys are considered a particularly vulnerable target to the toxic effects that PM 2.5 exerts. Alteration of kidney function may lead to a disrupted homeostasis, affecting disparate tissues in the body. This review intends to summarize all relevant knowledge published between January 2000 and December 2021 on the effects of ambient PM 2.5 and the adverse effects on kidney function in adults (≥ 18 years). Results and Discussion: Studies published in peer-reviewed journals, written in English, regarding the effects of PM 2.5 on kidney function and the development and/or exacerbation of kidney disease(s) were included. Of the 587 nonduplicate studies evaluated, 40 were included, comprising of studies on healthy or diagnosed with pre-existing disease (sub)populations. Most of the studies were cohort studies (n = 27), followed by 10 cross-sectional, 1 ecological and 2 time-series studies. One longitudinal study was considered intermediate risk of bias, the other included studies were considered low risk of bias. A large portion of the studies (n = 36) showed that PM 2.5 exposure worsened kidney outcome(s) investigated; however, some studies show contradictory results. Measurement of the estimated glomerular filtration rate, for instance, was found to be positively associated (n = 8) as well as negatively associated (n = 4) with PM 2.5. Limitations and Conclusion: The main limitations of the included studies include residual confounding (e.g., smoking) and lack of individual exposure levels. The majority of included studies focused on specific subpopulations, which may limit generalizability. Evidence of the detrimental effects that ambient PM 2.5 may exert on kidney function is emerging. However, further investigations are required to determine how and to what extent air pollution, specifically PM 2.5 , exerts adverse effects on the kidney and alters its function. Registration: The systematic review protocol was submitted and published by the International Prospective Register of Systematic Reviews (PROSPERO; CRD42 02017 5615).-
dc.language.isoen-
dc.publisherBMC-
dc.rightsOpen Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.-
dc.subject.otherAir pollution-
dc.subject.otherFine particulate matter-
dc.subject.otherPM 25-
dc.subject.otherKidney-
dc.subject.otherKidney disease-
dc.titleAdverse Effects of fine particulate matter on human kidney functioning: a systematic review-
dc.typeJournal Contribution-
dc.identifier.issue1-
dc.identifier.volume21-
local.bibliographicCitation.jcatA1-
local.publisher.placeCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND-
dc.relation.referencesReferences 1. Xu X, Nie S, Ding H, Hou FF. Environmental pollution and kidney diseases. Nature Reviews Nephrology. 2018;14(5):313. 2. Arnold R, Issar T, Krishnan AV, Pussell BA. Neurological complications in chronic kidney disease. JRSM cardiovascular disease. 2016;5:2048004016677687. 3. Wang XH, Mitch WE. Mechanisms of muscle wasting in chronic kidney disease. Nature Reviews Nephrology. 2014;10(9):504. 4. Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z. Estimates of the 2016 global burden of kidney disease attributable to ambient fine particulate matter air pollution. BMJ Open. 2019;9(5):e022450. 5. Lv J-C, Zhang L-X. Prevalence and disease burden of chronic kidney disease. Renal Fibrosis: Mechanisms and Therapies. 2019:3-15. 6. System USRD. 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020. 7. Loomis D, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, et al. The carcinogenicity of outdoor air pollution. Lancet Oncology. 2013;14(13):1262. 8. Elliott CT, Copes R. Burden of mortality due to ambient fine particulate air pollution (PM 2.5) in interior and Northern BC. Canadian journal of public health. 2011;102(5):390-3. 9. Shaddick G, Thomas M, Mudu P, Ruggeri G, Gumy S. Half the world’s population are exposed to increasing air pollution. NPJ Climate and Atmospheric Science. 2020;3(1):1-5. 10. Organization WH. WHO global air quality guidelines: particulate matter (PM2. 5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide: executive summary. 2021. 11. Nemmar A, Hoet PM, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts M, et al. Passage of inhaled particles into the blood circulation in humans. Circulation. 2002;105(4):411-4. 12. Bové H, Bongaerts E, Slenders E, Bijnens EM, Saenen ND, Gyselaers W, et al. Ambient black carbon particles reach the fetal side of human placenta. Nature communications. 2019;10(1):1-7. 13. Maher BA, Ahmed IA, Karloukovski V, MacLaren DA, Foulds PG, Allsop D, et al. Magnetite pollution nanoparticles in the human brain. Proceedings of the National Academy of Sciences. 2016;113(39):10797-801. 14. Saenen ND, Bové H, Steuwe C, Roeffaers MB, Provost EB, Lefebvre W, et al. Children’s urinary environmental carbon load. A novel marker reflecting residential ambient air pollution exposure? American journal of respiratory and critical care medicine. 2017;196(7):873-81. 15. Zhao Y, Cai J, Zhu X, van Donkelaar A, Martin RV, Hua J, et al. Fine particulate matter exposure and renal function: A population-based study among pregnant women in China. Environment International. 2020;141:105805. 16. Finn WF. Renal response to environmental toxics. Environmental health perspectives. 1977;20:15-26. 17. Moher D, Weeks L, Ocampo M, Seely D, Sampson M, Altman DG, et al. Describing reporting guidelines for health research: a systematic review. Journal of clinical epidemiology. 2011;64(7):718-42. 18. Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children. Clinical kidney journal. 2016;9(4):583-91. 19. Čukuranović R, Vlajković S. Age related anatomical and functional characteristics of human kidney. organ. 2005;7:14. 20. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses. Ottawa Health Research Institute: Ottawa, Ontario, 2010. 2015. 21. Fang J, Tang S, Zhou J, Zhou J, Cui L, Kong F, et al. Associations between Personal PM2. 5 Elemental Constituents and Decline of Kidney Function in Older Individuals: the China BAPE Study. Environmental Science & Technology. 2020;54(20):13167-74. 22. Blum MF, Surapaneni A, Stewart JD, Liao D, Yanosky JD, Whitsel EA, et al. Particulate Matter and Albuminuria, Glomerular Filtration Rate, and Incident CKD. Clin J Am Soc Nephrol. 2020;15(3):311-9. 23. Mehta AJ, Zanobetti A, Bind MA, Kloog I, Koutrakis P, Sparrow D, et al. Long-Term Exposure to Ambient Fine Particulate Matter and Renal Function in Older Men: The Veterans Administration Normative Aging Study. Environ Health Perspect. 2016;124(9):1353-60. 24. Li A, Mei Y, Zhao M, Xu J, Li R, Zhao J, et al. Associations between air pollutant exposure and renal function: A prospective study of older adults without chronic kidney disease. Environmental Pollution. 2021;277:116750. 25. Feng Y, Thijs L, Zhang Z-Y, Bijnens EM, Yang W-Y, Wei F-F, et al. Glomerular Function in Relation to Fine Airborne Particulate Matter in a Representative Population Sample. 2021. 26. Li Q, Wang Y-Y, Guo Y, Zhou H, Wang Q-M, Shen H-P, et al. Association between airborne particulate matter and renal function: An analysis of 2.5 million young adults. Environment International. 2021;147:106348. 27. Gao X, Koutrakis P, Coull B, Lin X, Vokonas P, Schwartz J, et al. Short-term exposure to PM2. 5 components and renal health: Findings from the Veterans Affairs Normative Aging Study. Journal of Hazardous Materials. 2021;420:126557. 28. Chuang KJ, Pan CH, Su CL, Lai CH, Lin WY, Ma CM, et al. Urinary neutrophil gelatinase-associated lipocalin is associated with heavy metal exposure in welding workers. Sci Rep. 2015;5:18048. 29. Weaver AM, Wang Y, Wellenius GA, Young B, Boyle LD, Hickson DA, et al. Long-term exposure to ambient air pollution and renal function in African Americans: the Jackson Heart Study. Journal of exposure science & environmental epidemiology. 2019;29(4):548. 30. Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, et al. Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China. J Am Soc Nephrol. 2016;27(12):3739-46. 31. Lin S-Y, Hsu W-H, Lin C-L, Lin C-C, Lin C-H, Wang I, et al. Association of exposure to fine-particulate air pollution and acidic gases with incidence of nephrotic syndrome. International Journal of Environmental Research and Public Health. 2018;15(12):2860. 32. Gu J, Shi Y, Zhu Y, Chen N, Wang H, Zhang Z, et al. Ambient air pollution and cause-specific risk of hospital admission in China: A nationwide time-series study. PLoS medicine. 2020;17(8):e1003188. 33. Bernatsky S, Fournier M, Pineau CA, Clarke AE, Vinet E, Smargiassi A. Associations between ambient fine particulate levels and disease activity in patients with systemic lupus erythematosus (SLE). Environ Health Perspect. 2011;119(1):45-9. 34. Bowe B, Xie Y, Yan Y, Xian H, Al-Aly Z. Diabetes Minimally Mediated the Association Between PM(2.5) Air Pollution and Kidney Outcomes. Sci Rep. 2020;10(1):4586. 35. Chin WS, Chang YK, Huang LF, Tsui HC, Hsu CC, Guo YL. Effects of long-term exposure to CO and PM(2.5) on microalbuminuria in type 2 diabetes. Int J Hyg Environ Health. 2018;221(4):602-8. 36. Bragg-Gresham J, Morgenstern H, McClellan W, Saydah S, Pavkov M, Williams D, et al. County-level air quality and the prevalence of diagnosed chronic kidney disease in the US Medicare population. PLoS ONE. 2018;13(7). 37. Chan TC, Zhang Z, Lin BC, Lin C, Deng HB, Chuang YC, et al. Long-term exposure to ambient fine particulate matter and chronic kidney disease: A cohort study. Environmental Health Perspectives. 2018;126(10). 38. Chen SY, Chu DC, Lee JH, Yang YR, Chan CC. Traffic-related air pollution associated with chronic kidney disease among elderly residents in Taipei City. Environ Pollut. 2018;234:838-45. 39. Lin SY, Ju SW, Lin CL, Hsu WH, Lin CC, Ting IW, et al. Air pollutants and subsequent risk of chronic kidney disease and end-stage renal disease: A population-based cohort study. Environ Pollut. 2020;261:114154. 40. Ran J, Sun S, Han L, Zhao S, Chen D, Guo F, et al. Fine particulate matter and cause-specific mortality in the Hong Kong elder patients with chronic kidney disease. Chemosphere. 2020;247:125913. 41. Wang W, Wu C, Mu Z, Gu Y, Zheng Y, Ren L, et al. Effect of ambient air pollution exposure on renal dysfunction among hospitalized patients in Shanghai, China. Public Health. 2020;181:196-201. 42. Yang YR, Chen YM, Chen SY, Chan CC. Associations between Long-Term Particulate Matter Exposure and Adult Renal Function in the Taipei Metropolis. Environ Health Perspect. 2017;125(4):602-7. 43. Jung J, Park JY, Kim YC, Lee H, Kim E, Kim YS, et al. Effects of air pollution on mortality of patients with chronic kidney disease: A large observational cohort study. Science of The Total Environment. 2021;786:147471. 44. Ghazi L, Drawz PE, Berman JD. The association between fine particulate matter (PM2. 5) and chronic kidney disease using electronic health record data in urban Minnesota. Journal of exposure science & environmental epidemiology. 2021:1-7. 45. Liang Z, Wang W, Wang Y, Ma L, Liang C, Li P, et al. Urbanization, ambient air pollution, and prevalence of chronic kidney disease: A nationwide cross-sectional study. Environment International. 2021;156:106752. 46. Bo Y, Brook JR, Lin C, Chang L-y, Guo C, Zeng Y, et al. Reduced Ambient PM2. 5 Was Associated with a Decreased Risk of Chronic Kidney Disease: A Longitudinal Cohort Study. Environmental Science & Technology. 2021;55(10):6876-83. 47. Zeng Y, Lin C, Guo C, Bo Y, Chang L-y, Lau AK, et al. Combined effects of chronic PM2. 5 exposure and habitual exercise on renal function and chronic kidney disease: A longitudinal cohort study. Int J Hyg Environ Health. 2021;236:113791. 48. Li G, Huang J, Wang J, Zhao M, Liu Y, Guo X, et al. Long-term exposure to ambient PM2. 5 and increased risk of CKD prevalence in China. Journal of the American Society of Nephrology. 2021;32(2):448-58. 49. Kuźma Ł, Małyszko J, Bachórzewska-Gajewska H, Kralisz P, Dobrzycki S. Exposure to air pollution and renal function. Scientific Reports. 2021;11(1):1-9. 50. Wu C-D, Chern Y-R, Pan W-C, Lung S-CC, Yao T-C, Tsai H-J, et al. Effects of surrounding environment on incidence of end stage renal disease. Science of The Total Environment. 2020:137915. 51. Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z. Particulate matter air pollution and the risk of incident CKD and progression to ESRD. Journal of the American Society of Nephrology. 2018;29(1):218-30. 52. Ran J, Yang A, Sun S, Han L, Li J, Guo F, et al. Long-Term Exposure to Ambient Fine Particulate Matter and Mortality from Renal Failure: A Retrospective Cohort Study in Hong Kong. Am J Epidemiol. 2020. 53. Lin Y-T, Lo Y-C, Chiang H-Y, Jung C-R, Wang C-M, Chan T-C, et al. Particulate Air Pollution and Progression to Kidney Failure With Replacement Therapy: An Advanced CKD Registry–Based Cohort Study in Taiwan. American Journal of Kidney Diseases. 2020. 54. Bi J, Barry V, Weil EJ, Chang HH, Ebelt S. Short-term exposure to fine particulate air pollution and emergency department visits for kidney diseases in the Atlanta metropolitan area. Environmental Epidemiology. 2021;5(4). 55. Feng Y, Jones MR, Chu NM, Segev DL, McAdams-DeMarco M. Ambient air pollution and mortality among older patients initiating maintenance dialysis. American Journal of Nephrology. 2021;52(3):217-27. 56. Pierotti L, Schofield SJ, Collett D, Fecht D, De Hoogh K, Hansell AL, et al. Traffic-related air pollution and solid organ transplant failure in Great Britain: A retrospective cohort study. Journal of Transport and Health. 2018;10:124-31. 57. Chang S-H, Merzkani M, Murad H, Wang M, Bowe B, Lentine KL, et al. Association of ambient fine particulate matter air pollution with kidney transplant outcomes. JAMA network open. 2021;4(10):e2128190-e. 58. Dehom S, Knutsen S, Shavlik D, Bahjri K, Ali H, Pompe L, et al. Long-Term Exposure to Fine Particulate Matter (PM2. 5) and Cardiovascular Disease Mortality among Renal Transplant Recipients. OBM Transplantation. 2019;3(4):1-. 59. Feng Y, Jones MR, Ahn JB, Garonzik‐Wang JM, Segev DL, McAdams‐DeMarco M. Ambient air pollution and posttransplant outcomes among kidney transplant recipients. American Journal of Transplantation. 2021. 60. WHO's global air-quality guidelines. Lancet (London, England). 2006;368(9544):1302. 61. Levey AS, Coresh J, Tighiouart H, Greene T, Inker LA. Measured and estimated glomerular filtration rate: current status and future directions. Nature reviews Nephrology. 2019:1-14. 62. Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro III AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Annals of internal medicine. 2009;150(9):604-12. 63. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Annals of internal medicine. 1999;130(6):461-70. 64. Cheung KL, Lafayette RA. Renal physiology of pregnancy. Adv Chronic Kidney Dis. 2013;20(3):209-14. 65. Masson I, Flamant M, Maillard N, Rule AD, Vrtovsnik F, Peraldi M-N, et al. MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients. Transplantation. 2013;95(10):1211-7. 66. Chen Y-W, Chen H-H, Wang T-E, Chang C-W, Chang C-W, Wu C-J. Difference between CKD-EPI and MDRD equations in calculating glomerular filtration rate in patients with cirrhosis. World Journal of Gastroenterology: WJG. 2011;17(40):4532. 67. Eknoyan G, Lameire N, Eckardt K, Kasiske B, Wheeler D, Levin A, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3(1):5-14. 68. Bikbov B, Perico N, Abbate M, Remuzzi G. The Glomerulus: Mechanisms and Patterns of Injury. Comprehensive Toxicology: Third Edition2017. p. 189-206. 69. Pennemans V, De Winter LM, Munters E, Nawrot TS, Van Kerkhove E, Rigo J-M, et al. The association between urinary kidney injury molecule 1 and urinary cadmium in elderly during long-term, low-dose cadmium exposure: a pilot study. Environmental Health. 2011;10(1):1-7. 70. Genovese F, Manresa AA, Leeming DJ, Karsdal MA, Boor P. The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? Fibrogenesis & tissue repair. 2014;7(1):4. 71. Lamb EJ, Path F, Price CP. 21 Kidney Function Tests—Creatinine, Urea, and Uric Acid. Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics-E-Book. 2014:364. 72. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function. New England Journal of Medicine. 2013;369(10):932-43. 73. Argyropoulos CP, Chen SS, Ng Y-H, Roumelioti M-E, Shaffi K, Singh PP, et al. Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases. Frontiers in medicine. 2017;4:73. 74. Penders J, Delanghe JR. Alpha 1-microglobulin: clinical laboratory aspects and applications. Clinica chimica acta. 2004;346(2):107-18. 75. Norden AG, Lapsley M, Unwin RJ. Urine retinol-binding protein 4: a functional biomarker of the proximal renal tubule. Advances in clinical chemistry. 2014;63:85-122. 76. Ronco P, Debiec H. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care. The Lancet. 2015;385(9981):1983-92. 77. Bernatsky S, Smargiassi A, Johnson M, Kaplan GG, Barnabe C, Svenson L, et al. Fine particulate air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary, Alberta. Environmental research. 2015;140:474-8. 78. Faustini A, Renzi M, Kirchmayer U, Balducci M, Davoli M, Forastiere F. Short-term exposure to air pollution might exacerbate autoimmune diseases. Environmental Epidemiology. 2018;2(3):e025. 79. Darrow LA, Klein M, Flanders WD, Mulholland JA, Tolbert PE, Strickland MJ. Air pollution and acute respiratory infections among children 0–4 years of age: an 18-year time-series study. American journal of epidemiology. 2014;180(10):968-77. 80. Zhao J, Li M, Wang Z, Chen J, Zhao J, Xu Y, et al. Role of PM 2.5 in the development and progression of COPD and its mechanisms. Respiratory Research. 2019;20(1):120. 81. Long M-h, Zhang C, Xu D-q, Fu W-l, Gan X-d, Li F, et al. PM2. 5 aggravates diabetes via the systemically activated IL-6-mediated STAT3/SOCS3 pathway in rats’ liver. Environmental Pollution. 2020;256:113342. 82. Heck TG, Fiorin PBG, Frizzo MN, Ludwig MS. Fine Particulate Matter (PM2. 5) Air Pollution and Type 2 Diabetes Mellitus (T2DM): When Experimental Data Explains Epidemiological Facts. Diabetes and Its Complications. 2018:71. 83. Pecoits-Filho R, Abensur H, Betônico CC, Machado AD, Parente EB, Queiroz M, et al. Interactions between kidney disease and diabetes: dangerous liaisons. Diabetology & metabolic syndrome. 2016;8(1):50. 84. Xu X, Liu C, Xu Z, Tzan K, Zhong M, Wang A, et al. Long-term exposure to ambient fine particulate pollution induces insulin resistance and mitochondrial alteration in adipose tissue. Toxicological Sciences. 2011;124(1):88-98. 85. Zelnick LR, Weiss NS, Kestenbaum BR, Robinson-Cohen C, Heagerty PJ, Tuttle K, et al. Diabetes and CKD in the United States population, 2009–2014. Clinical Journal of the American Society of Nephrology. 2017;12(12):1984-90. 86. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine. 2004;351(13):1296-305. 87. Kundu S, Stone EA. Composition and sources of fine particulate matter across urban and rural sites in the Midwestern United States. Environmental Science: Processes & Impacts. 2014;16(6):1360-70. 88. Zhang Z, Chang L-y, Lau AK, Chan T-C, Chieh Chuang Y, Chan J, et al. Satellite-based estimates of long-term exposure to fine particulate matter are associated with C-reactive protein in 30 034 Taiwanese adults. International journal of epidemiology. 2017;46(4):1126-36. 89. Pugh D, Gallacher PJ, Dhaun N. Management of hypertension in chronic kidney disease. Drugs. 2019;79(4):365-79. 90. Hodgkins KS, Schnaper HW. Tubulointerstitial injury and the progression of chronic kidney disease. Pediatric nephrology. 2012;27(6):901-9. 91. Pandey P, Patel D, Khan A, Barman S, Murthy R, Kisku G. Temporal distribution of fine particulates (PM2. 5, PM10), potentially toxic metals, PAHs and Metal-bound carcinogenic risk in the population of Lucknow City, India. Journal of Environmental Science and Health, Part A. 2013;48(7):730-45.-
local.type.refereedRefereed-
local.type.specifiedReview-
local.bibliographicCitation.artnr24-
dc.identifier.doi10.1186/s12940-021-00827-7-
dc.identifier.isi000752910200001-
local.provider.typePdf-
local.uhasselt.uhpubyes-
local.uhasselt.internationalno-
item.contributorRASKING, Leen-
item.contributorVANBRABANT, Kenneth-
item.contributorBOVE, Hannelore-
item.contributorPLUSQUIN, Michelle-
item.contributorDe Vusser, Katrien-
item.contributorROELS, Harry-
item.contributorNAWROT, Tim-
item.fulltextWith Fulltext-
item.validationecoom 2023-
item.fullcitationRASKING, Leen; VANBRABANT, Kenneth; BOVE, Hannelore; PLUSQUIN, Michelle; De Vusser, Katrien; ROELS, Harry & NAWROT, Tim (2022) Adverse Effects of fine particulate matter on human kidney functioning: a systematic review. In: Environmental Health, 21 (1) (Art N° 24).-
item.accessRightsOpen Access-
crisitem.journal.eissn1476-069X-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Rasking_2022.pdfPublished version1.45 MBAdobe PDFView/Open
Show simple item record

WEB OF SCIENCETM
Citations

17
checked on May 2, 2024

Page view(s)

50
checked on Jul 20, 2022

Download(s)

12
checked on Jul 20, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.